Log In
BCIQ
Print this Print this
 

DA-3808

  Manage Alerts
Collapse Summary General Information
Company Dong-A Socio Holdings Co. Ltd.
DescriptionB-domain deleted recombinant Factor VII
Molecular Target
Mechanism of ActionFactor VIII replacement
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia
Regulatory Designation
PartnerDong-A ST Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today